Academia Open
Vol 10 No 1 (2025): June (In Progress)
Clinical Research

Evaluation Of Bacterial Pathogens And Antimicrobial Resistance In Blood Isolates From Febrile Cases At Medical City Hospital In Baghdad
Evaluasi Patogen Bakteri Dan Resistensi Antimikroba Pada Isolat Darah Dari Kasus Demam Di Rumah Sakit Kota Medis Di Baghdad


View Article
  • Huda Jihad G. Al-shattrawi*
Huda Jihad G. Al-shattrawi
Department of clinical Laboratory Science, Collage of Pharmacy, University of Thi -Qar, Iraq *

(*) Corresponding Author
Picture in here are illustration from public domain image or provided by the author, as part of their works
DOI: https://doi.org/10.21070/acopen.10.2025.10497
Published January 18, 2025
Keywords
  • Bloodstream infections,
  • Antimicrobial resistance,
  • Multidrug,
  • Cross-sectional research,
  • Microbiological analysis
How to Cite
Al-shattrawi, H. J. G. (2025). Evaluation Of Bacterial Pathogens And Antimicrobial Resistance In Blood Isolates From Febrile Cases At Medical City Hospital In Baghdad. Academia Open, 10(1), 10.21070/acopen.10.2025.10497. https://doi.org/10.21070/acopen.10.2025.10497

Copyright (c) 2025 Huda Jihad G. Al-shattrawi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Bacterial bloodstream infection is a critical public health issue due to its high morbidity and mortality rates. Prompt diagnosis and appropriate treatment are essential for improving patient outcomes. This study aimed to identify the bacterial composition of bloodstream infections and their antibiotic resistance patterns at Medical City Hospital, Baghdad. A cross-sectional study of 462 fever-diagnosed individuals (244 females, 218 males) conducted from July 3 to September 24, 2024, found that 96 (20.8%) had culture-positive bacteria. Staphylococcus aureus (30.21%) was the most prevalent, followed by coagulase-negative staphylococci (26.04%), Escherichia coli (10.42%), Enterobacter cloacae (8.34%), Streptococcus pyogenes (7.29%), Citrobacter spp. (6.25%), and Klebsiella spp. (5.25%). Antibiotic resistance was high, particularly to oxacillin (95.63%), ampicillin (97.79%), and gentamicin (88.54%). Multidrug resistance was identified in 87.49% of bacterial isolates, with susceptibility to cefotaxime, azithromycin, ceftriaxone, and ciprofloxacin. Notably, Gram-positive bacteria showed significant resistance to vancomycin and oxacillin (54.17%). These findings underscore the importance of routine susceptibility testing for pathogens and antibiotics to prevent the spread of resistant bacterial infections and guide effective treatment strategies.

Highlights:

  1. Identify bloodstream infection bacteria, analyze antibiotic resistance patterns.
  2. 20.8% culture-positive; Staphylococcus aureus most prevalent; high resistance.
  3. Multidrug resistance prevalent; emphasize susceptibility testing to manage resistance.

Keywords: Bloodstream infections, Antimicrobial resistance, Multidrug, Cross-sectional research, Microbiological analysis

View Article

Downloads

Download data is not yet available.

References

  1. D. J. Diekema, P. R. Hsueh, R. E. Mendes, M. A. Pfaller, K. V. Rolston, H. S. Sader, and R. N. Jones, "The Microbiology of Bloodstream Infection: 20-Year Trends From the SENTRY Antimicrobial Surveillance Program," Antimicrobial Agents and Chemotherapy, vol. 63, no. 7, pp. 10–1128, 2019.
  2. V. Schechner et al., "One-Year Mortality and Years of Potential Life Lost Following Bloodstream Infection Among Adults: A Nation-Wide Population-Based Study," The Lancet Regional Health–Europe, vol. 23, 2022.
  3. W. V. Kern and S. Rieg, "Burden of Bacterial Bloodstream Infection—A Brief Update on Epidemiology and Significance of Multidrug-Resistant Pathogens," Clinical Microbiology and Infection, vol. 26, no. 2, pp. 151–157, 2020.
  4. M. Goto and M. N. Al-Hasan, "Overall Burden of Bloodstream Infection and Nosocomial Bloodstream Infection in North America and Europe," Clinical Microbiology and Infection, vol. 19, no. 6, pp. 501–509, 2013.
  5. K. G. Miedema et al., "Bacteria Causing Bacteremia in Pediatric Cancer Patients Presenting With Febrile Neutropenia—Species Distribution and Susceptibility Patterns," Supportive Care in Cancer, vol. 21, pp. 2417–2426, 2013.
  6. M. Akova, "Epidemiology of Antimicrobial Resistance in Bloodstream Infections," Virulence, vol. 7, no. 3, pp. 252–266, 2016.
  7. V. Russotto et al., "Bloodstream Infections in Intensive Care Unit Patients: Distribution and Antibiotic Resistance of Bacteria," Infection and Drug Resistance, pp. 287–296, 2015.
  8. M. Mitiku, Z. Ayenew, and K. Desta, "Multidrug Resistant, Extended Spectrum Beta-Lactamase and Carbapenemase Producing Bacterial Isolates Among Septicemia Suspected Under Five Children in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: Cross-Sectional Study," 2019.
  9. F. Prestinaci, P. Pezzotti, and A. Pantosti, "Antimicrobial Resistance: A Global Multifaceted Phenomenon," Pathogens and Global Health, vol. 109, no. 7, pp. 309–318, 2015.
  10. J. Bengtsson-Palme, E. Kristiansson, and D. J. Larsson, "Environmental Factors Influencing the Development and Spread of Antibiotic Resistance," FEMS Microbiology Reviews, vol. 42, no. 1, fux053, 2018.
  11. J. F. Timsit, E. Ruppé, F. Barbier, A. Tabah, and M. Bassetti, "Bloodstream Infections in Critically Ill Patients: An Expert Statement," Intensive Care Medicine, vol. 46, no. 2, pp. 266–284, 2020.
  12. J. F. Timsit et al., "Treatment of Bloodstream Infections in ICUs," BMC Infectious Diseases, vol. 14, pp. 1–11, 2014.
  13. S. Di Franco et al., "Bloodstream Infections From MDR Bacteria," Life, vol. 11, no. 6, p. 575, 2021.
  14. A. D. Aziz, "Secondary Bacterial Infections Among Hospitalized COVID-19 Patients in Erbil City-Iraq," Doctoral dissertation, Salahaddin University-Erbil, 2023.
  15. R. Asreah, S. Atta, and S. SarKo, "Clinical Characteristics and Antibiotics Sensitivity of Culture Positive Typhoid Fever Patients in Baghdad Teaching Hospital—A Single Center Study," Open Access Maced. J. Med. Sci., vol. 10, no. B, pp. 1846–1856, Feb. 2022.
  16. Z. S. Shakir et al., "Pattern of Bacterial Infections in Neutropenic Febrile Patients (Experience of the Specialized BMT Center-Medical City Complex-Baghdad, Iraq)," Iraqi Journal of Hematology, vol. 13, no. 1, pp. 122–131, 2024.
  17. A. A. J. Aljanaby and I. A. J. Aljanaby, "Prevalence of Aerobic Pathogenic Bacteria Isolated From Patients With Burn Infection and Their Antimicrobial Susceptibility Patterns in Al-Najaf City, Iraq—A Three-Year Cross-Sectional Study," F1000Research, vol. 7, p. 1157, 2018.
  18. J. Ali and Y. Kebede, "Frequency of Isolation and Antimicrobial Susceptibility Pattern of Bacterial Isolates From Blood Culture, Gondar University Teaching Hospital, Northwest Ethiopia," Ethiopian Medical Journal, vol. 46, no. 2, pp. 155–161, 2008.
  19. R. N. Costilow, Manual of Methods for General Bacteriology. American Society for Microbiology, 1981.
  20. P. A. Wayne, "National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Testing," Twelfth Informational Supplement (M100-S12), 2002.
  21. J. L. Chen et al., "Characterization of Methicillin-Resistant Staphylococcus aureus Isolates From Periprosthetic Joint Infections," Pathogens, vol. 11, no. 7, p. 719, 2022.
  22. C. von Eiff, R. A. Proctor, and G. Peters, "Coagulase-Negative Staphylococci: Pathogens Have Major Role in Nosocomial Infections," Postgraduate Medicine, vol. 110, no. 4, pp. 63–76, 2001.
  23. Y. W. Tang et al., "StaphPlex System for Rapid and Simultaneous Identification of Antibiotic Resistance Determinants and Panton-Valentine Leukocidin Detection of Staphylococci From Positive Blood Cultures," Journal of Clinical Microbiology, vol. 45, no. 6, pp. 1867–1873, 2007.
  24. A. Parmanik et al., "Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review," Current Microbiology, vol. 79, no. 12, p. 388, 2022.
  25. T. Naas et al., "Neonatal Infections With Multidrug-Resistant ESBL-Producing E. Cloacae and K. Pneumoniae in Neonatal Units of Two Different Hospitals in Antananarivo, Madagascar," BMC Infectious Diseases, vol. 16, pp. 1–10, 2016.
  26. P. Wardhani, "Antimicrobial Resistance and Infection Control," International Conference on Prevention and Infection Control, vol. 12, no. 1, p. 81, 2023.
  27. M. P. Ventero et al., "Role of Relebactam in the Antibiotic Resistance Acquisition in Pseudomonas Aeruginosa: In Vitro Study," Antibiotics, vol. 12, no. 11, p. 1619, 2023.
  28. R. T. Saggers et al., "Challenges Facing PICUs in Low- and Middle-Income Countries in the Treatment of Emerging Multidrug-Resistant Organisms: A Review and Perspective From a South African PICU," Current Infectious Disease Reports, vol. 25, no. 11, pp. 233–242, 2023.
  29. T. M. Coque et al., "Antimicrobial Resistance in the Global Health Network: Known Unknowns and Challenges for Efficient Responses in the 21st Century," Microorganisms, vol. 11, no. 4, p. 1050, 2023.
  30. H. K. Tiwari and M. R. Sen, "Emergence of Vancomycin Resistant Staphylococcus aureus (VRSA) From a Tertiary Care Hospital From Northern Part of India," BMC Infectious Diseases, vol. 6, pp. 1–6, 2006.
  31. B. Ntozini, "Molecular Characterization of Invasive Streptococcus agalactiae in South Africa, 2019–2020," Doctoral dissertation, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2023.